St Petersburg University scientist Allan V. Kalueff becomes a member of the European Academy of Sciences
The Head of the Laboratory of Biological Psychiatry at the Institute of Translational Biomedicine at St Petersburg University has become a member of the European Academy of Sciences.
The European Academy of Sciences is a fully independent international association of distinguished scholars at the forefront of development and research that enables effective collaboration between academic staff, researchers, and public sector. Its mission is to promote excellence in science and technology and their essential roles in fostering social and economic development and progress.
Becoming a member of the European Academy of Sciences is only possible if you have received an invitation from a scientist who is engaged in the same field of research and personally knows the person who they propose for election. As a rule, they are world-recognised scientists who are actively engaged in publishing their works with high citation indexes. Today, about 80 Russian scientists in all fields of research are members of the European Academy of Sciences.
Any member of the European Academy of Sciences can choose only one affiliation as the main affiliation. Little wonder, I have chosen St Petersburg University. By doing so, I wanted to stress what contribution the University has made to foster my progress in research.
Allan Kalueff, Doctor of Biology and Head of the Laboratory of Biological Psychiatry at the Institute of Translational Biomedicine, St Petersburg University
Doctor of Biology Allan Kalueff is the Head of the Laboratory of Biological Psychiatry at the Institute of Translational Biomedicine at St Petersburg University and Director of the ZENEREI Research Centre (USA). He is also the President of the International Stress and Behaviour Society (ISBS). His h-index is 68, according to the Google Scholar, and 57, according to Scopus. His research interests are: translational biomedicine; biological psychiatry and psycho-pharmacology of anxiousness; depression; and preclinical models. He also focuses on modelling the nervous system disorders through studying molecular processes in rodents and zebrafish. This is what his doctorate dissertation concentrates on. He defended his dissertation in winter according to the rules and regulations of St Petersburg University. His findings can be found in 27 publications in English in highly cited international journals.
Opened in 2014 with support of the grant of the priority development of the Russian Science Foundation ‘Implementing the complex scientific programmes of organisations’, the Institute of Translational Biomedicine focuses on improving health of each person and society in general through translating the results of interdisciplinary research into diagnostic tools and techniques, medication and treatment, medical policy and education. Five years ago, the Institute of Translational Biomedicine opened the Laboratory of Biomedical Psychiatry. ‘From the moment when the Laboratory of Biomedical Psychiatry was opened, the University has always excelled in providing first class support,’ said Allan Kalueff. ‘Opening the Laboratory of Biomedical Psychiatry is a milestone in my research.’